HRP20190533T1 - Postupak za otkrivanje nukleosoma koji sadrže nukleotide - Google Patents
Postupak za otkrivanje nukleosoma koji sadrže nukleotide Download PDFInfo
- Publication number
- HRP20190533T1 HRP20190533T1 HRP20190533TT HRP20190533T HRP20190533T1 HR P20190533 T1 HRP20190533 T1 HR P20190533T1 HR P20190533T T HRP20190533T T HR P20190533TT HR P20190533 T HRP20190533 T HR P20190533T HR P20190533 T1 HRP20190533 T1 HR P20190533T1
- Authority
- HR
- Croatia
- Prior art keywords
- dna base
- body fluid
- fluid sample
- detecting
- binding agent
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
-
- G01N33/57515—
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
-
- G01N33/5751—
-
- G01N33/5752—
-
- G01N33/57525—
-
- G01N33/5753—
-
- G01N33/57535—
-
- G01N33/57545—
-
- G01N33/5755—
-
- G01N33/57555—
-
- G01N33/57585—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161530295P | 2011-09-01 | 2011-09-01 | |
| GBGB1115095.0A GB201115095D0 (en) | 2011-09-01 | 2011-09-01 | Method for detecting nucleosomes containing nucleotides |
| EP12756549.7A EP2751568B1 (en) | 2011-09-01 | 2012-08-31 | Method for detecting nucleosomes containing nucleotides |
| PCT/GB2012/052128 WO2013030577A1 (en) | 2011-09-01 | 2012-08-31 | Method for detecting nucleosomes containing nucleotides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20190533T1 true HRP20190533T1 (hr) | 2019-06-28 |
Family
ID=44882046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20190533TT HRP20190533T1 (hr) | 2011-09-01 | 2012-08-31 | Postupak za otkrivanje nukleosoma koji sadrže nukleotide |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US10900064B2 (enExample) |
| EP (2) | EP3483608B1 (enExample) |
| JP (1) | JP6322845B2 (enExample) |
| KR (1) | KR102074528B1 (enExample) |
| CN (1) | CN104067124B (enExample) |
| AU (1) | AU2012300641B2 (enExample) |
| BR (1) | BR112014005087B1 (enExample) |
| CA (1) | CA2845993C (enExample) |
| DK (1) | DK2751568T3 (enExample) |
| ES (1) | ES2717659T3 (enExample) |
| GB (1) | GB201115095D0 (enExample) |
| HR (1) | HRP20190533T1 (enExample) |
| HU (1) | HUE043386T2 (enExample) |
| MX (1) | MX364410B (enExample) |
| PL (1) | PL2751568T3 (enExample) |
| PT (1) | PT2751568T (enExample) |
| RU (2) | RU2687483C2 (enExample) |
| SG (2) | SG11201400270PA (enExample) |
| TR (1) | TR201904386T4 (enExample) |
| WO (1) | WO2013030577A1 (enExample) |
| ZA (1) | ZA201401295B (enExample) |
Families Citing this family (78)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10081839B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
| US11111544B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US11111543B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US10083273B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US20110178719A1 (en) | 2008-08-04 | 2011-07-21 | Gene Security Network, Inc. | Methods for Allele Calling and Ploidy Calling |
| ES2640776T3 (es) | 2009-09-30 | 2017-11-06 | Natera, Inc. | Métodos para denominar de forma no invasiva ploidía prenatal |
| US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
| US12152275B2 (en) | 2010-05-18 | 2024-11-26 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| EP2854058A3 (en) | 2010-05-18 | 2015-10-28 | Natera, Inc. | Methods for non-invasive pre-natal ploidy calling |
| US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
| US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US12221653B2 (en) | 2010-05-18 | 2025-02-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| RU2620959C2 (ru) | 2010-12-22 | 2017-05-30 | Натера, Инк. | Способы неинвазивного пренатального установления отцовства |
| RU2671980C2 (ru) | 2011-02-09 | 2018-11-08 | Натера, Инк. | Способы неинвазивного пренатального установления плоидности |
| GB201115095D0 (en) | 2011-09-01 | 2011-10-19 | Singapore Volition Pte Ltd | Method for detecting nucleosomes containing nucleotides |
| US20140100126A1 (en) | 2012-08-17 | 2014-04-10 | Natera, Inc. | Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data |
| EP2775304A1 (en) * | 2013-03-07 | 2014-09-10 | Universitätsspital Basel | Methods for detecting inflammatory disorder |
| US10262755B2 (en) | 2014-04-21 | 2019-04-16 | Natera, Inc. | Detecting cancer mutations and aneuploidy in chromosomal segments |
| US10577655B2 (en) | 2013-09-27 | 2020-03-03 | Natera, Inc. | Cell free DNA diagnostic testing standards |
| US9499870B2 (en) * | 2013-09-27 | 2016-11-22 | Natera, Inc. | Cell free DNA diagnostic testing standards |
| CN106460070B (zh) | 2014-04-21 | 2021-10-08 | 纳特拉公司 | 检测染色体片段中的突变和倍性 |
| US12492429B2 (en) | 2014-04-21 | 2025-12-09 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
| US20180173846A1 (en) | 2014-06-05 | 2018-06-21 | Natera, Inc. | Systems and Methods for Detection of Aneuploidy |
| CN107002021B (zh) * | 2014-09-30 | 2021-12-03 | 深圳华大基因科技有限公司 | 类风湿性关节炎的生物标记物及其用途 |
| EP3809140A1 (en) | 2014-10-29 | 2021-04-21 | Belgian Volition SPRL | Method for the enrichment of circulating tumor dna |
| US11391742B2 (en) * | 2015-02-10 | 2022-07-19 | B.R.A.H.M.S. Gmbh | Free histone proteins as biomarkers |
| US11479812B2 (en) | 2015-05-11 | 2022-10-25 | Natera, Inc. | Methods and compositions for determining ploidy |
| EP4450636A3 (en) | 2015-05-18 | 2025-01-01 | Karius, Inc. | Compositions and methods for enriching populations of nucleic acids |
| GB201511542D0 (en) * | 2015-07-01 | 2015-08-12 | Singapore Volition Pte Ltd | Use of cell free nucleosomes as biomarkers |
| GB201511512D0 (en) * | 2015-07-01 | 2015-08-12 | Singapore Volition Pte Ltd | Use of cell-free nucleosomes as biomarkers |
| GB201518674D0 (en) * | 2015-10-21 | 2015-12-02 | Singapore Volition Pte Ltd | Method for detecting nuleosomes containing histone modifications and variants |
| GB201518665D0 (en) | 2015-10-21 | 2015-12-02 | Singapore Volition Pte Ltd | Method for enrichment of cell free nucleosomes |
| GB201604806D0 (en) * | 2016-03-22 | 2016-05-04 | Singapore Volition Pte Ltd | Method of identifying a cancer of unknown origin |
| ES2913468T3 (es) | 2016-04-15 | 2022-06-02 | Natera Inc | Métodos para la detección del cáncer de pulmón. |
| CN107858416B (zh) * | 2016-09-19 | 2021-05-28 | 深圳华大生命科学研究院 | 用于子宫内膜异位症检测的生物标志物组合及其应用 |
| WO2018067517A1 (en) | 2016-10-04 | 2018-04-12 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
| GB201618485D0 (en) | 2016-11-02 | 2016-12-14 | Ucl Business Plc | Method of detecting tumour recurrence |
| US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
| US10894976B2 (en) | 2017-02-21 | 2021-01-19 | Natera, Inc. | Compositions, methods, and kits for isolating nucleic acids |
| CN107164508A (zh) * | 2017-06-16 | 2017-09-15 | 上海易毕恩基因科技有限公司 | 用于检测肝癌的基因标志物及其用途 |
| CN107385051A (zh) * | 2017-08-04 | 2017-11-24 | 上海易毕恩生物技术有限公司 | 用于检测肝肿瘤良恶性的基因标志物、试剂盒及检测方法 |
| US12084720B2 (en) | 2017-12-14 | 2024-09-10 | Natera, Inc. | Assessing graft suitability for transplantation |
| WO2019161244A1 (en) | 2018-02-15 | 2019-08-22 | Natera, Inc. | Methods for isolating nucleic acids with size selection |
| EP4215621B1 (en) * | 2018-03-01 | 2025-05-28 | Epicypher, Inc. | Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes |
| JP7573443B2 (ja) | 2018-04-14 | 2024-10-25 | ナテラ， インコーポレイテッド | 循環腫瘍ｄｎａの個別化された検出を用いる癌検出およびモニタリングの方法 |
| US12234509B2 (en) | 2018-07-03 | 2025-02-25 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
| GB201818963D0 (en) | 2018-11-21 | 2019-01-09 | Belgian Volition Sprl | Methof for the detection of prostate cancer |
| GB201818965D0 (en) | 2018-11-21 | 2019-01-09 | Belgian Volition Sprl | Method for the detection of colorectal cancer |
| GB201906199D0 (en) | 2019-05-02 | 2019-06-19 | Belgian Volition Sprl | Method for the detection of cancer |
| GB201906201D0 (en) | 2019-05-02 | 2019-06-19 | Belgian Voltion Sprl | Method for the detection of protate cancer |
| WO2020247263A1 (en) | 2019-06-06 | 2020-12-10 | Natera, Inc. | Methods for detecting immune cell dna and monitoring immune system |
| GB201912251D0 (en) | 2019-08-27 | 2019-10-09 | Belgian Volition Sprl | Method of isolating circulating nucleosomes |
| US20220290252A1 (en) | 2019-08-27 | 2022-09-15 | Belgian Volition Srl | Method of isolating circulating nucleosomes |
| WO2021110776A1 (en) | 2019-12-02 | 2021-06-10 | Belgian Volition Sprl | Use of cell free nucleosomes as biomarkers |
| MX2022011614A (es) | 2020-03-20 | 2022-10-13 | Belgian Volition Srl | Metodo de triaje utilizando niveles de nucleosomas libres de celulas. |
| TW202238131A (zh) | 2020-11-25 | 2022-10-01 | 比利時商比利時意志有限公司 | 測量無細胞核蛋白染色質片段之方法 |
| TW202242145A (zh) | 2020-12-29 | 2022-11-01 | 比利時商比利時意志有限公司 | 核小體耗盡循環無細胞染色質片段之轉錄因子結合位點分析 |
| TW202242130A (zh) | 2020-12-29 | 2022-11-01 | 比利時商比利時意志有限公司 | 循環轉錄因子分析 |
| TW202242146A (zh) | 2021-01-13 | 2022-11-01 | 比利時商比利時意志有限公司 | 肺癌的檢測方法 |
| GB202108185D0 (en) | 2021-06-08 | 2021-07-21 | Belgian Volition Sprl | Standardisation of nucleosome assays using biologically derived calibrants |
| GB202108452D0 (en) | 2021-06-14 | 2021-07-28 | Belgian Volition Sprl | Triaging method using cell free nucleosome levels |
| WO2023073179A1 (en) | 2021-10-29 | 2023-05-04 | Belgian Volition Srl | Homogeneous immunoassay method |
| GB202117799D0 (en) | 2021-12-09 | 2022-01-26 | Belgian Volition Srl | Method for the detection of blood cancer |
| EP4490323A1 (en) | 2022-03-11 | 2025-01-15 | Belgian Volition SRL | Differential diagnosis method |
| GB202205212D0 (en) | 2022-04-08 | 2022-05-25 | Belgian Volition Sprl | Method for transplant organ health assessment |
| EP4577833A1 (en) | 2022-08-25 | 2025-07-02 | Belgian Volition SRL | Method for measuring cell free chromatin |
| EP4639165A1 (en) | 2022-12-19 | 2025-10-29 | Belgian Volition SRL | Assessment of biological samples for nucleic acid analysis |
| GB202300607D0 (en) | 2023-01-16 | 2023-03-01 | Belgian Volition Srl | Proteins and methods for isolating circulating nucleosomes |
| GB202303562D0 (en) | 2023-03-10 | 2023-04-26 | Belgian Volition Sprl | Sample collection for liquid biopsy |
| WO2025061853A1 (en) | 2023-09-19 | 2025-03-27 | Belgian Volition Srl | Lateral flow test device |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2652901A1 (fr) | 1989-10-11 | 1991-04-12 | Pasteur Institut | Complexes biologiques a base de nucleosomes, et leurs applications, notamment dans le domaine du diagnostic in vitro du lupus erythemateux dissemine (led). |
| US6630301B1 (en) * | 1997-03-14 | 2003-10-07 | The Penn State Research Foundation | Detection of extracellular tumor-associated nucleic acid in blood plasma or serum |
| PT938320E (pt) * | 1996-03-26 | 2010-09-22 | Michael S Kopreski | Método que permite a utilização de arn extracelular extraído de plasma ou de soro para detectar, monitorizar ou avaliar o cancro |
| AU2934299A (en) * | 1998-03-18 | 1999-10-11 | Roche Diagnostics Gmbh | Detection of apoptotic products |
| NL1014106C2 (nl) | 2000-01-18 | 2001-07-20 | Univ Amsterdam | Werkwijze voor het detecteren van een pathologische afwijking bij een cel, een antistof en een assay kit. |
| MXPA05014238A (es) | 2003-07-04 | 2006-03-09 | Johnson & Johnson Res Pty Ltd | Metodo para la deteccion de citosina alquilada en adn. |
| GB0319376D0 (en) | 2003-08-18 | 2003-09-17 | Chroma Therapeutics Ltd | Histone modification detection |
| WO2005040814A1 (en) * | 2003-10-14 | 2005-05-06 | Cancer Research Technology Limited | Methods and means of cancer detection by histone modification |
| WO2006071608A2 (en) * | 2004-12-16 | 2006-07-06 | President And Fellows Of Harvard College | Histone demethylation mediated by the nuclear amine oxidase homolog lsd1 |
| DE102005034628B4 (de) * | 2005-07-19 | 2007-08-23 | Epigenomics Ag | Verfahren zur Untersuchung von Cytosin-Methylierungen in DNA |
| WO2007050706A2 (en) | 2005-10-27 | 2007-05-03 | University Of Missouri-Columbia | Dna methylation biomarkers in lymphoid and hematopoietic malignancies |
| WO2007049286A1 (en) * | 2005-10-27 | 2007-05-03 | Tata Memorial Centre | A system for ex-vivo separation of apoptotic chromatin particles from blood or plasma |
| JP2009517404A (ja) | 2005-11-28 | 2009-04-30 | メディミューン，エルエルシー | Ｈｍｇｂ１および／またはｒａｇｅのアンタゴニストならびにその使用方法 |
| DE102006035600B3 (de) | 2006-07-27 | 2007-11-08 | Epigenomics Ag | Verfahren zum Nachweis eines Methylierungsmusters |
| US20080131954A1 (en) * | 2006-11-30 | 2008-06-05 | Canon U.S. Life Sciences, Inc. | Method of Separating Target DNA from Mixed DNA |
| US20100151468A1 (en) * | 2007-04-11 | 2010-06-17 | Manel Esteller | Epigenetic biomarkers for early detection, therapeutic effectiveness, and relapse monitoring of cancer |
| US7608402B2 (en) * | 2008-01-10 | 2009-10-27 | Weiwei Li | DNA methylation specific signal amplification |
| WO2009115313A1 (en) | 2008-03-19 | 2009-09-24 | Oryzon Genomics, S.A. | Method and composition for methylation analysis |
| PT2865387T (pt) | 2008-11-21 | 2019-09-27 | Kobenhavns Univ University Of Copenhagen | Iniciação de uma resposta imunitária |
| JP2012524278A (ja) | 2009-04-14 | 2012-10-11 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | がんの臨床診断および予後診断のためのヒストン修飾パターン |
| EP2462245B1 (en) | 2009-08-06 | 2016-10-05 | Cornell University | Device and methods for epigenetic analysis |
| EP2561367A1 (en) | 2010-04-22 | 2013-02-27 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Means and methods for identifying an increased risk of systemic lupus erythematosus (sle) patients for developing renal manifestations |
| US20130078642A1 (en) | 2010-06-03 | 2013-03-28 | Porto Conte Richerche S.R.L. | Biomarkers for lung neuroendocrine tumors |
| FI20105715A0 (fi) | 2010-06-18 | 2010-06-18 | Helsingin Yliopisto | Asetyloituun HMGB1:een sitoutuva polyklonaalinen vasta-aine |
| CN101955998A (zh) * | 2010-07-20 | 2011-01-26 | 赵英仁 | 一种血浆游离dna水平检测肝细胞坏死程度的方法 |
| GB201115095D0 (en) | 2011-09-01 | 2011-10-19 | Singapore Volition Pte Ltd | Method for detecting nucleosomes containing nucleotides |
| GB201115098D0 (en) | 2011-09-01 | 2011-10-19 | Belgian Volition Sa | Method for detecting nucleosomes containing histone variants |
| MX356986B (es) * | 2011-12-07 | 2018-06-22 | Singapore Volition Pte Ltd | Metodo para detectar aductos de nucleosomas. |
| US9605313B2 (en) | 2012-03-02 | 2017-03-28 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| GB201303575D0 (en) | 2013-02-28 | 2013-04-10 | Singapore Volition Pte Ltd | Method for detecting histone modifications in nucleosomes |
-
2011
- 2011-09-01 GB GBGB1115095.0A patent/GB201115095D0/en not_active Ceased
-
2012
- 2012-08-31 JP JP2014527737A patent/JP6322845B2/ja active Active
- 2012-08-31 HR HRP20190533TT patent/HRP20190533T1/hr unknown
- 2012-08-31 PT PT12756549T patent/PT2751568T/pt unknown
- 2012-08-31 RU RU2017126701A patent/RU2687483C2/ru active
- 2012-08-31 SG SG11201400270PA patent/SG11201400270PA/en unknown
- 2012-08-31 KR KR1020147008108A patent/KR102074528B1/ko not_active Expired - Fee Related
- 2012-08-31 EP EP18212025.3A patent/EP3483608B1/en active Active
- 2012-08-31 TR TR2019/04386T patent/TR201904386T4/tr unknown
- 2012-08-31 ES ES12756549T patent/ES2717659T3/es active Active
- 2012-08-31 WO PCT/GB2012/052128 patent/WO2013030577A1/en not_active Ceased
- 2012-08-31 CA CA2845993A patent/CA2845993C/en active Active
- 2012-08-31 MX MX2014002443A patent/MX364410B/es active IP Right Grant
- 2012-08-31 BR BR112014005087-2A patent/BR112014005087B1/pt not_active IP Right Cessation
- 2012-08-31 AU AU2012300641A patent/AU2012300641B2/en not_active Ceased
- 2012-08-31 DK DK12756549.7T patent/DK2751568T3/en active
- 2012-08-31 SG SG10201601153RA patent/SG10201601153RA/en unknown
- 2012-08-31 EP EP12756549.7A patent/EP2751568B1/en active Active
- 2012-08-31 RU RU2014112350/15A patent/RU2014112350A/ru unknown
- 2012-08-31 PL PL12756549T patent/PL2751568T3/pl unknown
- 2012-08-31 HU HUE12756549A patent/HUE043386T2/hu unknown
- 2012-08-31 CN CN201280053555.1A patent/CN104067124B/zh not_active Expired - Fee Related
- 2012-08-31 US US14/239,783 patent/US10900064B2/en active Active
-
2014
- 2014-02-20 ZA ZA2014/01295A patent/ZA201401295B/en unknown
-
2020
- 2020-05-15 US US16/875,856 patent/US20200347435A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20190533T1 (hr) | Postupak za otkrivanje nukleosoma koji sadrže nukleotide | |
| JP2014529405A5 (enExample) | ||
| JP2018536849A5 (enExample) | ||
| JP2014531573A5 (enExample) | ||
| JP2008536098A5 (enExample) | ||
| JP2008529008A5 (enExample) | ||
| RU2014112348A (ru) | Способ детекции нуклеосом, содержащих гистоновые варианты | |
| JP2017215338A5 (enExample) | ||
| Thornton | Detection of invasive aspergillosis | |
| SG10201408392PA (en) | Methods of determining patient response by measurement of her-3 | |
| JP2014144959A5 (enExample) | ||
| ATE554389T1 (de) | Apex als marker für lungenkrebs | |
| Leung et al. | Ovarian cancer biomarkers: current state and future implications from high-throughput technologies | |
| WO2009121024A3 (en) | Methods for detecting antibodies | |
| JP2019516104A5 (enExample) | ||
| JP2017524933A5 (enExample) | ||
| BRPI0919987A8 (pt) | Dispositivo biosensor magnético e método para aplicar um campo magnético em uma superfície do sensor de um dispositivo biosensor magnético | |
| Sari et al. | The stability study of electrochemical aptasensor to detect SARS-CoV-2 spike protein and its application for clinical samples of nasopharyngeal swab | |
| WO2011159741A3 (en) | Tetranor-pgem/pgam specific immunogens, antibodies, tracers, assay kits and methods for making same | |
| JP2012515893A5 (enExample) | ||
| HRP20200229T1 (hr) | Uporaba izvanstaničnih nukleosoma kao biomarkera u fekalnim uzorcima | |
| HRP20200476T1 (hr) | Prognostički postupak i pribor koristan za navedeni postupak | |
| UA138712U (uk) | Спосіб прогнозування розвитку остеоартрозу | |
| UA131135U (uk) | Спосіб прогнозування розвитку остеоартрозу | |
| Kurahara et al. | Prediction of Postoperative Early Recurrence and Prognosis in Pancreatic Cancer Patients |